Indian investors ride out big-pharma slump with small-cap drugmakers

Share:
Facebook Twitter Google+

MUMBAI (Reuters) – Investors in Indian pharmaceutical stock, hit by quality-related sanctions against drugmakers operating abroad and reduced pricing power in more profitable markets, have adopted a new mantra: patience and pickiness.
Reuters: Money News